CVS Health Corp vs Financial Select Sector SPDR Fund — how do they compare? CVS Health Corp trades at $86.2 (market cap $112.49B), while Financial Select Sector SPDR Fund trades at $54.22 (market cap $50.96B). The key difference: CVS Health Corp is far larger — about 2.2× Financial Select Sector SPDR Fund's market cap, and CVS Health Corp pays a 3.02% dividend while Financial Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Financial Select Sector SPDR Fund for 104 Days on average.
| CVS | XLF | |
|---|---|---|
Market Cap | $112.49B | $50.96B |
Volume | 8,467,392 | 35,821,731 |
Sector | Health | — |
52-Week High | $110.60 | $58.55 |
52-Week Low | $70.08 | $47.80 |
Typical Hold Time | 83 Days | 104 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
XLF trades at $53.75, down 0.48% with a bearish technical signal as financial stocks lag the broader market. The ETF faces headwinds from rising interest rates and regulatory changes, though higher rates could benefit bank profitability. Recent news highlights sector rotation into financials by fund managers despite underperformance relative to the S&P 500.
The outlook remains cautious with technical indicators showing bearish momentum, though oversold conditions may present entry opportunities. Key risks include interest rate sensitivity and regulatory uncertainty, while potential catalysts include continued Fed tightening and improved bank earnings. Wall Street sentiment is mixed with institutional positioning favoring financials.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →